Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin.
Leissring MA, Malito E, Hedouin S, Reinstatler L, Sahara T, Abdul-Hay SO, Choudhry S, Maharvi GM, Fauq AH, Huzarska M, May PS, Choi S, Logan TP, Turk BE, Cantley LC, Manolopoulou M, Tang WJ, Stein RL, Cuny GD, Selkoe DJ.
Leissring MA, et al. Among authors: manolopoulou m.
PLoS One. 2010 May 7;5(5):e10504. doi: 10.1371/journal.pone.0010504.
PLoS One. 2010.
PMID: 20498699
Free PMC article.